Olmesartan Decreased Levels of IL-1β and TNF-α, Down-Regulated MMP-2, MMP-9, COX-2, RANK/RANKL and Up-Regulated SOCs-1 in an Intestinal Mucositis Model-Reference-Cited by-同舟云学术

Olmesartan Decreased Levels of IL-1β and TNF-α, Down-Regulated MMP-2, MMP-9, COX-2, RANK/RANKL and Up-Regulated SOCs-1 in an Intestinal Mucositis Model

Published:2014-12-22 Issue:12 Volume:9 Page:e114923
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Araújo Júnior Raimundo Fernandes de,da Silva Reinaldo Maria Patrícia Oliveira,Brito Gerly Anne de Castro,Cavalcanti Pedro de França,Freire Marco Aurélio de Moura,de Medeiros Caroline Addison Xavier,de Araújo Aurigena Antunes

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients;ST Sonis;Cancer,2004

2. The pathobiology of mucositis;ST Sonis;Nat Rev Cancer,2004

3. Novel antifolate drugs;WT Purcell;Curr Oncol Rep,2003

4. Mechanisms of action of methotrexate;ES Chan;Bull Hosp Jt Dis (2013),2013

5. Proanthocyanidin prevents methotrexate-induced intestinal damage and oxidative stress;M Gulgun;Exp Toxicol Pathol,2010

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms underlying methotrexate-induced intestinal injury and protective strategies;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-01

2. Gallic Acid Protects Against Methotrexate-Induced Intestinal Mucositis; Oxidative Stress, Histopathology and Inflammatory Status;Jundishapur Journal of Natural Pharmaceutical Products;2023-10-17

3. Stem cell biotherapy: A new remedy for Trichinella spiralis-induced inflammatory myopathy;Parasitology International;2023-10

4. Gel formulated with Bryophyllum pinnatum leaf extract promotes skin wound healing in vivo by increasing VEGF expression: A novel potential active ingredient for pharmaceuticals;Frontiers in Pharmacology;2023-01-12

5. Immunomodulatory Activity of the Most Commonly Used Antihypertensive Drugs—Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers;International Journal of Molecular Sciences;2022-02-04